GS0051: Cells for medical use, namely, for use in creating cell-based therapies encapsulating peptide and protein antigens for the treatment of auto-immune or aberrant immune activation disorders for medical purposes
GS0441: Cell-based therapy services for the treatment of auto-immune or aberrant immune activation disorders featuring cells encapsulating peptide and protein antigens for medical purposes
D10000: "TOLERIZING ANTIGEN CARRIERS"
Case File Event Statements
5/1/2023 - a year ago
45 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDType:MAB6
5/1/2023 - a year ago
44 - ABANDONMENT - NO USE STATEMENT FILEDType:ABN6
9/16/2022 - 2 years ago
43 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
9/14/2022 - 2 years ago
42 - SOU EXTENSION 4 GRANTEDType:EX4G
9/14/2022 - 2 years ago
41 - SOU EXTENSION 4 FILEDType:EXT4
9/14/2022 - 2 years ago
40 - SOU TEAS EXTENSION RECEIVEDType:EEXT
3/12/2022 - 2 years ago
39 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA
3/10/2022 - 2 years ago
38 - SOU EXTENSION 3 GRANTEDType:EX3G
3/10/2022 - 2 years ago
37 - SOU EXTENSION 3 FILEDType:EXT3
3/10/2022 - 2 years ago
36 - SOU TEAS EXTENSION RECEIVEDType:EEXT
9/1/2021 - 3 years ago
35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDType:EXRA